Given the size of the stroke depicted in Figure 1 (greater than one third of the hemisphere), thrombolytic therapy would be contraindicated for this patient. Indications of a hemorrhagic stroke ...

Stroke is the second leading cause of death globally and a major contributor to adult disability. According to the World Health Organization, approximately 15 million people suffer a stroke annually—5 ...

Scientists have discovered novel drug candidates which could ultimately lead to new effective treatments for conditions caused by tissue stress and inflammation, including neuropathic pain and ...

Traumatic brain injury (TBI) and ischemic stroke are major public health concerns and leading causes of death and disability worldwide. A research team led by City University of Hong Kong (CityU) ...

CNW/ - Hoffmann-La Roche Limited (Roche Canada) is proud to announce that Health Canada has granted market authorization for ...

Brain edema is a life-threatening condition where excess fluid causes the brain to swell. The primary medical treatment involves hyperosmolar agents like mannitol and hypertonic saline to draw fluid ...

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...